Long-term outcomes of elagolix in women with endometriosis (2018)
Fonte: Obstetrics and gynecology. Nome do evento: 73rd Scientific Congress and Expo of the American-Society-for-Reproductive-Medicine (ASRM). Unidade: FM
Assuntos: ENDOMETRIOSE, HORMÔNIO LIBERADOR DE GONADOTROFINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SURREY, Eric et al. Long-term outcomes of elagolix in women with endometriosis. Obstetrics and gynecology, v. 132, n. 1, p. 147-160, 2018Tradução . . Disponível em: https://doi.org/10.1097/AOG.0000000000002675. Acesso em: 10 nov. 2024.APA
Surrey, E., Taylor, H. S., Giudice, L., Lessey, B. A., Abrao, M. S., Archer, D. F., et al. (2018). Long-term outcomes of elagolix in women with endometriosis. Obstetrics and gynecology, 132( 1), 147-160. doi:10.1097/AOG.0000000000002675NLM
Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC. Long-term outcomes of elagolix in women with endometriosis [Internet]. Obstetrics and gynecology. 2018 ; 132( 1): 147-160.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1097/AOG.0000000000002675Vancouver
Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC. Long-term outcomes of elagolix in women with endometriosis [Internet]. Obstetrics and gynecology. 2018 ; 132( 1): 147-160.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1097/AOG.0000000000002675
